Answer
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead should not be used during breastfeeding because information on its components’ effects in newborns/infants is insufficient; emtricitabine enters human milk, excretion of the other components is unknown, and women living with HIV should not breastfeed to avoid HIV transmission.
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead 150mg/150mg/200mg/10mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 37Document updated
Sources checked